[
  {
    "name": "ABACAVIR",
    "risk": "High",
    "severity": "Severe",
    "confidence": 0.97,
    "gene": "HLA-B",
    "diplotype": "*57:01",
    "phenotype": "Hypersensitivity Risk",
    "phenotypeLabel": "Immune Reaction",
    "cpic": "Level A",
    "dosage": "Avoid use",
    "alternative": "Tenofovir",
    "mechanism": "Immune-mediated reaction",
    "whyRisk": "HLA-B*57:01 associated with severe hypersensitivity",
    "variants": ["rs2395029"],
    "geneImpact": 98,
    "category": "Infectious Disease"
  },
  {
    "name": "AMITRIPTYLINE",
    "risk": "Moderate",
    "severity": "Moderate",
    "confidence": 0.90,
    "gene": "CYP2D6",
    "diplotype": "*4/*5",
    "phenotype": "Poor Metabolizer",
    "phenotypeLabel": "Reduced Clearance",
    "cpic": "Level A",
    "dosage": "Reduce dose",
    "alternative": "Sertraline",
    "mechanism": "Reduced metabolism",
    "whyRisk": "Elevated plasma concentration increases side effects",
    "variants": ["rs3892097"],
    "geneImpact": 85,
    "category": "Psychiatry"
  },
  {
    "name": "ATOMOXETINE",
    "risk": "Moderate",
    "severity": "Moderate",
    "confidence": 0.88,
    "gene": "CYP2D6",
    "diplotype": "*10/*4",
    "phenotype": "Intermediate Metabolizer",
    "phenotypeLabel": "Slower Metabolism",
    "cpic": "Level A",
    "dosage": "Adjust dose",
    "alternative": "Methylphenidate",
    "mechanism": "Reduced metabolism",
    "whyRisk": "Higher systemic exposure",
    "variants": ["rs1065852"],
    "geneImpact": 82,
    "category": "Psychiatry"
  },
  {
    "name": "AZATHIOPRINE",
    "risk": "High",
    "severity": "Severe",
    "confidence": 0.95,
    "gene": "TPMT",
    "diplotype": "*3A/*3C",
    "phenotype": "Low Activity",
    "phenotypeLabel": "Poor Metabolizer",
    "cpic": "Level A",
    "dosage": "Reduce drastically or avoid",
    "alternative": "Mycophenolate",
    "mechanism": "Impaired thiopurine metabolism",
    "whyRisk": "Severe myelosuppression risk",
    "variants": ["rs1142345"],
    "geneImpact": 93,
    "category": "Immunology"
  },
  {
    "name": "CAPECITABINE",
    "risk": "High",
    "severity": "Severe",
    "confidence": 0.96,
    "gene": "DPYD",
    "diplotype": "*2A",
    "phenotype": "Deficient Metabolizer",
    "phenotypeLabel": "Low DPD Activity",
    "cpic": "Level A",
    "dosage": "Avoid or reduce significantly",
    "alternative": "Non-fluoropyrimidine therapy",
    "mechanism": "Reduced drug breakdown",
    "whyRisk": "Severe toxicity risk",
    "variants": ["rs3918290"],
    "geneImpact": 97,
    "category": "Oncology"
  },

  {
    "name": "CARBAMAZEPINE",
    "risk": "High",
    "severity": "Severe",
    "confidence": 0.94,
    "gene": "HLA-B",
    "diplotype": "*15:02",
    "phenotype": "High Risk",
    "phenotypeLabel": "Severe Cutaneous Reaction",
    "cpic": "Level A",
    "dosage": "Avoid use",
    "alternative": "Levetiracetam",
    "mechanism": "Immune reaction",
    "whyRisk": "Risk of Stevens-Johnson Syndrome",
    "variants": ["rs3909184"],
    "geneImpact": 95,
    "category": "Neurology"
  },

  {
    "name": "CITALOPRAM",
    "risk": "Moderate",
    "severity": "Moderate",
    "confidence": 0.89,
    "gene": "CYP2C19",
    "diplotype": "*2/*2",
    "phenotype": "Poor Metabolizer",
    "phenotypeLabel": "Reduced Clearance",
    "cpic": "Level A",
    "dosage": "Reduce dose",
    "alternative": "Sertraline",
    "mechanism": "Reduced metabolism",
    "whyRisk": "QT prolongation risk",
    "variants": ["rs4244285"],
    "geneImpact": 84,
    "category": "Psychiatry"
  },

  {
    "name": "CODEINE",
    "risk": "High",
    "severity": "Severe",
    "confidence": 0.95,
    "gene": "CYP2D6",
    "diplotype": "*1/*1xN",
    "phenotype": "Ultra-Rapid Metabolizer",
    "phenotypeLabel": "Excess Morphine Production",
    "cpic": "Level A",
    "dosage": "Avoid use",
    "alternative": "Morphine",
    "mechanism": "Increased conversion",
    "whyRisk": "Respiratory depression risk",
    "variants": ["rs1065852"],
    "geneImpact": 94,
    "category": "Pain Management"
  },

  {
    "name": "FLUOROURACIL",
    "risk": "High",
    "severity": "Severe",
    "confidence": 0.96,
    "gene": "DPYD",
    "diplotype": "*2A",
    "phenotype": "Poor Metabolizer",
    "phenotypeLabel": "Low DPD Activity",
    "cpic": "Level A",
    "dosage": "Avoid or major reduction",
    "alternative": "Alternative chemotherapy",
    "mechanism": "Reduced degradation",
    "whyRisk": "Life-threatening toxicity",
    "variants": ["rs3918290"],
    "geneImpact": 97,
    "category": "Oncology"
  },

  {
    "name": "PHENYTOIN",
    "risk": "High",
    "severity": "Severe",
    "confidence": 0.93,
    "gene": "CYP2C9",
    "diplotype": "*2/*3",
    "phenotype": "Poor Metabolizer",
    "phenotypeLabel": "Reduced Clearance",
    "cpic": "Level A",
    "dosage": "Reduce dose",
    "alternative": "Levetiracetam",
    "mechanism": "Reduced metabolism",
    "whyRisk": "Toxic plasma concentration",
    "variants": ["rs1057910"],
    "geneImpact": 90,
    "category": "Neurology"
  },

  {
    "name": "TACROLIMUS",
    "risk": "Moderate",
    "severity": "Moderate",
    "confidence": 0.91,
    "gene": "CYP3A5",
    "diplotype": "*3/*3",
    "phenotype": "Non-Expresser",
    "phenotypeLabel": "Reduced Clearance",
    "cpic": "Level A",
    "dosage": "Lower initial dose",
    "alternative": "Sirolimus",
    "mechanism": "Reduced metabolism",
    "whyRisk": "Nephrotoxicity risk",
    "variants": ["rs776746"],
    "geneImpact": 88,
    "category": "Transplant"
  },
  {
    "name": "WARFARIN",
    "risk": "High",
    "severity": "Severe",
    "confidence": 0.92,
    "gene": "CYP2C9",
    "diplotype": "*2/*3",
    "phenotype": "Poor Metabolizer",
    "phenotypeLabel": "Low Enzyme Activity",
    "cpic": "Level A",
    "dosage": "Reduce dose significantly",
    "alternative": "Apixaban",
    "mechanism": "Reduced metabolism",
    "whyRisk": "Increased bleeding risk",
    "variants": ["rs1057910"],
    "geneImpact": 90,
    "category": "Cardiology"
    },
    {
    "name": "CLOPIDOGREL",
    "risk": "Moderate",
    "severity": "Moderate",
    "confidence": 0.88,
    "gene": "CYP2C19",
    "diplotype": "*2/*2",
    "phenotype": "Poor Metabolizer",
    "phenotypeLabel": "Reduced Activation",
    "cpic": "Level A",
    "dosage": "Increase dose or alternative",
    "alternative": "Prasugrel",
    "mechanism": "Reduced activation",
    "whyRisk": "Reduced antiplatelet effect",
    "variants": ["rs4244285"],
    "geneImpact": 85,
    "category": "Cardiology"
    },
    {
    "name": "SIMVASTATIN",
    "risk": "Moderate",
    "severity": "Moderate",
    "confidence": 0.87,
    "gene": "SLCO1B1",
    "diplotype": "*5/*5",
    "phenotype": "Low Function",
    "phenotypeLabel": "Reduced Transport",
    "cpic": "Level A",
    "dosage": "Lower dose",
    "alternative": "Pravastatin",
    "mechanism": "Reduced hepatic uptake",
    "whyRisk": "Myopathy risk",
    "variants": ["rs4149056"],
    "geneImpact": 80,
    "category": "Cardiology"
    },
    {
    "name": "ABACAVIR",
    "risk": "High",
    "severity": "Severe",
    "confidence": 0.97,
    "gene": "HLA-B",
    "diplotype": "*57:01",
    "phenotype": "Hypersensitivity Risk",
    "phenotypeLabel": "Immune Reaction",
    "cpic": "Level A",
    "dosage": "Avoid use",
    "alternative": "Tenofovir",
    "mechanism": "Immune-mediated reaction",
    "whyRisk": "HLA-B*57:01 associated with severe hypersensitivity",
    "variants": ["rs2395029"],
    "geneImpact": 98,
    "category": "Infectious Disease"
  },

  {
    "name": "GEFITINIB",
    "risk": "Low",
    "severity": "Mild",
    "confidence": 0.85,
    "gene": "EGFR",
    "diplotype": "*1/*1",
    "phenotype": "Normal",
    "phenotypeLabel": "Normal Activity",
    "cpic": "Level B",
    "dosage": "Standard dosing",
    "alternative": "",
    "mechanism": "EGFR pathway inhibition",
    "whyRisk": "No known PGx interaction",
    "variants": [],
    "geneImpact": 75,
    "category": "Oncology"
  },

  {
    "name": "METFORMIN",
    "risk": "Low",
    "severity": "Mild",
    "confidence": 0.88,
    "gene": "SLC22A1",
    "diplotype": "*1/*1",
    "phenotype": "Normal Transporter Function",
    "phenotypeLabel": "Normal Response",
    "cpic": "Level B",
    "dosage": "Standard dosing",
    "alternative": "",
    "mechanism": "Reduced hepatic glucose production via AMPK activation",
    "whyRisk": "No clinically actionable pharmacogenomic variants detected affecting metformin transport or clearance.",
    "variants": ["rs622342"],
    "geneImpact": 72,
    "category": "Endocrinology"
  },

  {
    "name": "PIROXICAM",
    "risk": "Moderate",
    "severity": "Moderate",
    "confidence": 0.87,
    "gene": "CYP2C9",
    "diplotype": "*1/*3",
    "phenotype": "Intermediate Metabolizer",
    "phenotypeLabel": "Reduced Clearance",
    "cpic": "Level B",
    "dosage": "Consider dose reduction",
    "alternative": "Celecoxib",
    "mechanism": "Reduced CYP2C9-mediated metabolism increases plasma concentration",
    "whyRisk": "CYP2C9 reduced function alleles may increase NSAID exposure and gastrointestinal toxicity risk.",
    "variants": ["rs1057910", "rs1799853"],
    "geneImpact": 85,
    "category": "Pain Management"
  }
]